A comparative study on the time to achieve negative nucleic acid testing and hospital stays between danoprevir and lopinavir/ritonavir in the treatment of patients with COVID‐19

In late December 2019, coronavirus disease 2019 (COVID‐19) first broke out in Wuhan, China, and has now become a global pandemic. However, there is no specific antiviral treatment for COVID‐19. This study enrolled 33 COVID‐19 patients in the nineth hospital of Nanchang from 27th January to 24th February 2020. Clinical indexes of patients upon admission/discharge were examined. Patients were divided into two groups according to different...